Analysis on the risk of myocarditis caused by PD-1/PD-L1 inhibitors based on FDA adverse event reporting system

YIN Yue-song, WU Yu-pei, LI Yang, ZHANG Li-na

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (11) : 76-80.

PDF(388 KB)
Welcome to visit Clinical Medication Journal!
PDF(388 KB)
Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (11) : 76-80. DOI: 10.3969/j.issn.1672-3384.2023.11.015
Original Article

Analysis on the risk of myocarditis caused by PD-1/PD-L1 inhibitors based on FDA adverse event reporting system

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(11): 76-80 https://doi.org/10.3969/j.issn.1672-3384.2023.11.015

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(388 KB)

Accesses

Citation

Detail

Sections
Recommended

/